How to Address Resistance Mechanisms Against RAS Therapies Observed in Colorectal Cancer
Time: 1:30 pm
day: Day One Track B PM
Details:
- Understanding resistance mechanisms dynamics in CRC and their implications to develop more effective therapies
- An overview of the consequences of resistance mechanisms in CRC patients to improve patient outcomes and QoL
- Developing strategies to overcome acquired resistance to RAS inhibition in CRC beyond targeting the RAS pathway
